TEVA(US:TEVA) Globenewswire·2025-11-19 13:00Core Insights - Teva Pharmaceutical Industries Ltd. has launched Teva Rise, a global open innovation platform aimed at leveraging disruptive technologies such as AI and digital health to address challenges in the pharmaceutical industry and enhance patient outcomes [1][2][4] Company Initiatives - Teva Rise is designed to connect startups and technology companies with Teva's business units, facilitating the co-creation of solutions to real-world challenges in R&D, manufacturing, and commercial sectors [1][3][6] - The initiative is part of Teva's "Pivot to Growth" strategy, which focuses on transforming the company into a leading biopharmaceutical entity by adopting next-generation technologies [2][4][9] Investment and Collaboration - Teva plans to invest tens of millions of dollars in innovative solutions over the coming years to gain a competitive edge [3][4] - The platform will allow selected startups to pilot their solutions within Teva's global operations, thereby scaling their impact [3][9] Challenges Addressed - Teva Rise will focus on seven specific challenges, including human-predictive platforms for testing biologics, AI-powered clinical trial simulations, and optimizing patient experience with long-acting injectables [10] - Each challenge will be sponsored by a senior business leader at Teva, ensuring alignment with the company's strategic priorities [3][10] Industry Context - The launch of Teva Rise is timely as the pharmaceutical industry undergoes significant transformation driven by AI and digital technologies, which are reshaping drug development and patient care [2][4] - By fostering global partnerships with startups and tech innovators, Teva aims to enhance its operational capabilities and deliver meaningful value to patients worldwide [4][6]